⌘K

Login Start Free

Home/Filings/4/0001127602-22-005469

4//SEC Filing

Spurr Robert 4

Accession 0001127602-22-005469

CIK 0000885590other

View on SEC.gov Company Profile

Filed

Feb 16, 7:00 PM ET

Accepted

Feb 17, 4:36 PM ET

Size

4.8 KB

Accession

0001127602-22-005469

Insider Transaction Report

Form 4

Period: 2022-02-15

Bausch Health Companies Inc.BHC

President, Salix

Transactions

Sale
Common Shares, No Par Value
2022-02-15$25.02/sh−3,251$81,340→ 60,299 total

Footnotes (1)

[F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.

Documents

1 file

4
form4.xmlPrimary
PRIMARY DOCUMENT

Issuer

Bausch Health Companies Inc.

CIK 0000885590

Entity typeother

Related Parties

1

filerCIK 0001543795

Filing Metadata

Form type: 4
Filed: Feb 16, 7:00 PM ET
Accepted: Feb 17, 4:36 PM ET
Size: 4.8 KB

View on SEC.gov